Advertisement

Prevalence of Chlamydia trachomatis, Trichomonas vaginalis and Neisseria gonorrhoeae Based on Data Collected by a Network of Clinical Microbiology Laboratories, in Italy

  • Maria Cristina SalfaEmail author
  • Barbara Suligoi
  • Italian STI Laboratory-based Surveillance Working Group
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 901)

Abstract

Bacterial and protozoal sexually transmitted infections (STIs), such as Chlamydia trachomatis, Trichomonas vaginalis and Neisseria gonorrhoeae, may cause acute symptoms, chronic infections and severe long-term complications. The complications of these infections in women include pelvic inflammatory disease, chronic pelvic pain, tubal infertility, ectopic pregnancy, and infertility. Moreover, infection during pregnancy is associated with premature rupture of the membranes, low birth weight and miscarriage.

In Italy, Chlamydia trachomatis and Trichomonas vaginalis infections are not subject to mandatory reporting; while gonorrhoea is subject to mandatory reporting.

To extend surveillance to STIs that are widespread yet often asymptomatic and to improve the knowledge on the epidemiology of these infections in Italy, in 2009 the “Centro Operativo AIDS of the Istituto Superiore di SanitÁ”, in collaboration with the Association of Italian Clinical Microbiologists (AMCLI, Associazione Microbiologi Clinici Italiani), launched the sentinel STIs surveillance system based on a network of 13 clinical microbiology laboratories.

The main objective of the surveillance was to assess the prevalence and risk factors associated with Chlamydia trachomatis, Trichomonas vaginalis and Neisseria gonorrhoea infections among individuals attending microbiology laboratories in Italy.

Keywords

Prevalence Microbiology laboratories Chlamydia trachomatis Trichomonas vaginalis Neisseria gonorrhoeae Risk factors 

Notes

Acknowledgements

The authors wish to thank Lindstedt Finn Ragnar for his assistance in revising the manuscript.

References

  1. Adams EJ, Charlett A, Edmunds WJ, Hughes G (2004) Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect 80(5):354–362. ReviewCrossRefPubMedPubMedCentralGoogle Scholar
  2. Barbosa MJ, Moherdaui F, Pinto VM, Ribeiro D, Cleuton M, Miranda AE (2010) Prevalence of Neisseria gonorrhoeae and Chlamydia trachomatis infection in men attending STD clinics in Brazil. Rev Soc Bras Med Trop 43(5):500–503CrossRefPubMedGoogle Scholar
  3. Desai S, Meyer T, Thamm M, Hamouda O, Bremer V (2011) Prevalence of Chlamydia trachomatis among young German adolescents, 2005–06. Sex Health 8(1):120–122CrossRefPubMedGoogle Scholar
  4. European Centre for Disease Prevention and Control (ECDC) (2014) Sexually transmitted infections in Europe 1990–2012. ECDC (Surveillance Report, 2014), StockholmGoogle Scholar
  5. Fenton KA, Lowndes CM (2004) Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect 80(4):255–263 (Review)CrossRefPubMedPubMedCentralGoogle Scholar
  6. Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Wellings K, Mercer CH, Carder C, Copas AJ, Nanchahal K, Macdowall W, Ridgway G, Field J, Erens B (2001) Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 358:1.851–1.854CrossRefGoogle Scholar
  7. Geelen TH, Hoebe CJ, Dirks A, Dukers-Muijrers NH, van Bergen JE, Wolffs PF (2013) Low positivity rate after systematic screening for Trichomonas vaginalis in three patient cohorts from general practitioners, STI clinic and a national population-based chlamydia screening study. Sex Transm Infect 89(6):532–534. doi: 10.1136/sextrans-2012-051010. Epub 2013 Jul 2CrossRefPubMedGoogle Scholar
  8. Goulet V, de Barbeyrac B, Raherison S, Prudhomme M, Semaille C, Warszawski J, CSF group (2010) Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France. Sex Transm Infect 86(4):263–270CrossRefPubMedGoogle Scholar
  9. Grama DF, Casarotti Lda S, Morato MG, Silva LS, Mendonça DF, Limongi JE, Viana Jda C, Cury MC (2013) Prevalence of Trichomonas vaginalis and risk factors in women treated at public health units in Brazil: a transversal study. Trans R Soc Trop Med Hyg 107(9):584–591. doi: 10.1093/trstmh/trt063. Epub 2013 Jul 22CrossRefPubMedGoogle Scholar
  10. Greco D, Giuliani M, Suligoi B, Panatta M, Giannetti A (1990) Sexually transmitted diseases in Italy: clinical returns versus statutory notifications. Genitourin Med 66(5):383–386PubMedPubMedCentralGoogle Scholar
  11. Grio R, Bello L, Smirne C, D’Addato F, Latino MA, Corvetto L, De Intinis G, Spagnolo E, Maffei S, Leotta E (2004) Chlamydia trachomatis prevalence in North-West Italy. Minerva Ginecol 56:401–406PubMedGoogle Scholar
  12. Kucinskiene V, Sutaite I, Valiukeviciene S, Milasauskiene Z, Domeika M (2006) Prevalence and risk factors of genital Chlamydia trachomatis infection. Medicina (Kaunas) 42:885–894Google Scholar
  13. Mitchell HD, Lewis DA, Marsh K, Hughes G (2014) Distribution and risk factors of Trichomonas vaginalis infection in England: an epidemiological study using electronic health records from sexually transmitted infection clinics, 2009–2011. Epidemiol Infect 142(8):1678–1687. doi: 10.1017/S0950268813002902. Epub 2013 Nov 29CrossRefPubMedGoogle Scholar
  14. Navarro C, Jolly A, Nair R, Chen Y (2002) Risk factors for genital chlamydial infection. Can J Infect Dis 13:195–207CrossRefPubMedPubMedCentralGoogle Scholar
  15. Piperaki ET, Theodora M, Mendris M, Barbitsa L, Pitiriga V, Antsaklis A, Tsakris A (2010) Prevalence of Trichomonas vaginalis infection in women attending a major gynaecological hospital in Greece: a cross-sectional study. J Clin Pathol 63(3):249–253CrossRefPubMedGoogle Scholar
  16. Poole DN, McClelland RS (2013) Global epidemiology of Trichomonas vaginalis. Sex Transm Infect 89(6):418–422. doi: 10.1136/sextrans-2013-051075. Epub 2013 Jun 6. Review. Erratum in: Sex Transm Infect. 2014 Feb;90(1):75
  17. Rao GG, Bacon L, Evans J, Dejahang Y, Michalczyk P, Donaldson N, Lewisham Chlamydia and Gonoccoccus Screening Programme (2008) Prevalence of Neisseria gonorrhoeae infection in young subjects attending community clinics in South London. Sex Transm Infect 84(2):117–121CrossRefPubMedGoogle Scholar
  18. Redmond SM, Alexander-Kisslig K, Woodhall SC, van den Broek IV, van Bergen J, Ward H, Uusküla A, Herrmann B, Andersen B, Götz HM, Sfetcu O, Low N (2015) Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis. PLoS One 10(1):e0115753. doi: 10.1371/journal.pone.0115753. eCollection 2015 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Salfa MC, Latino MA, Regine V, De Maria D, De Intinis G, Camoni L, Raimondo M, Suligoi B (2011a) Prevalence and determinants of Chlamydia trachomatis infection among sexually active women in Turin, Italy. Ital J Public Health 8(3):295–301Google Scholar
  20. Salfa MC, Latino MA, Regine V, De Maria D, De Intinis G, Camoni L, Raimondo M, Suligoi B (2011b) Prevalence and determinants of Chlamydia trachomatis infection among sexually active women in Turin, Italy. Ital J Public Health 8(3):295–301Google Scholar
  21. Salfa MC, Regine V, Ferri M, Suligoi B e la (2015) Rete Sentinella dei Centri Clinici e dei Laboratori di microbiologia clinica per le Infezioni Sessualmente Trasmesse. Le Infezioni Sessualmente Trasmesse: aggiornamento dei dati dei due sistemi di sorveglianza sentinella attivi in Italia al 31 dicembre 2013. Notiziario Istituto Superiore Sanità 28(2):3–43Google Scholar
  22. Samarawickrema N, Tabrizi S, Young E, Gunawardena P, Garland S (2014) Prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae and human papillomavirus in a sexual health clinic setting in urban Sri Lanka. Int J STD AIDS. pii: 0956462414552813. [Epub ahead of print]Google Scholar
  23. Stevens-Simon C, Sheeder J (2005) Chlamydia trachomatis: common misperceptions and misunderstandings. J Pediatr Adolesc Gynecol 18(4):231–243CrossRefPubMedGoogle Scholar
  24. Sutton M, Stenberg M, Koumans EH, Mcquillan G, Berman S, Markowitz L (2007) The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. CID 45(10):1.319–1.326CrossRefGoogle Scholar
  25. Sviben M, Missoni EM, Meštrović T, Vojnović G, Galinović GM (2015) Epidemiology and laboratory characteristics of Trichomonas vaginalis infection in Croatian men with and without urethritis syndrome: a case-control study. Sex Transm Infect. pii: sextrans-2014-051771. doi: 10.1136/sextrans-2014-051771. [Epub ahead of print]
  26. Uddin RN, Ryder N, McNulty AM, Wray L, Donovan B (2011) Trichomonas vaginalis infection among women in a low prevalence setting. Sex Health 8(1):65–68. doi: 10.1071/SH09147 CrossRefPubMedGoogle Scholar
  27. Verteramo R, Calzolari E, Degener AM, Masciangelo R, Patella A (2008) Trichomonas vaginalis infection: risk indicators among women attending for routine gynecologic examination. J Obstet Gynaecol Res 34(2):233–237CrossRefPubMedGoogle Scholar
  28. Wangnapi RA, Soso S, Unger HW, Sawera 1C, Ome M, Umbers AJ, Ndrewei N, Siba P, Li Wai Suen CSN, Vallely A, Wapling J, Ryan C, Mueller I, Rogerson SJ (2015) Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in Papua New Guinea. Sex Transm Infect 91(3):194–200. doi: 10.1136/sextrans-2014-051670. Epub 2014 Oct 13
  29. Wilson JS, Honey E, Templeton A, Paavonen J, Mardh PA, Stary A, Stray-Pedersen B (2002) A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update 8(4):385–394CrossRefPubMedGoogle Scholar
  30. World Health Organization (2012) Global incidence and prevalence of curable sexually transmitted infections. WHO Library Cataloguing-in-Publication Data. WHO, GenevaGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Maria Cristina Salfa
    • 1
    Email author
  • Barbara Suligoi
    • 1
  • Italian STI Laboratory-based Surveillance Working Group
  1. 1.Centro Operativo AIDS, Dipartimento Malattie Infettive, Parassitarie ed Immunomediate, Istituto Superiore di SanitàRomeItaly

Personalised recommendations